Profile data is unavailable for this security.
About the company
JD Health International Inc is a China-based investment holding company principally engaged in the Internet + Healthcare ecosystem business. The Company mainly providing pharmaceutical and healthcare products and Internet healthcare, health management, intelligent healthcare solutions to the customers, as well as a variety of marketing services to the business partners. The Company mainly conducts its businesses in domestic market.
- Revenue in HKD (TTM)57.86bn
- Net income in HKD2.31bn
- Incorporated2018
- Employees3.12k
- LocationJD Health International Inc8th Floor, Building C No. 18 Kechuang 11, Yizhuang Economic and TechnologicalDevelopment Zone, Daxing DistrictBEIJING 101111ChinaCHN
- Websitehttps://ir.jdhealth.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LBX Pharmacy Chain JSC | 24.26bn | 964.36m | 20.18bn | 35.61k | 20.84 | 2.79 | -- | 0.8315 | 1.53 | 1.53 | 38.54 | 11.44 | 1.08 | 4.21 | 12.21 | 630,212.90 | 5.37 | 6.01 | 10.80 | 13.64 | 31.46 | 32.67 | 4.98 | 5.14 | 0.4576 | 7.42 | 0.5695 | 30.58 | 28.54 | 21.88 | 17.29 | 16.18 | 0.2168 | -1.87 |
| Sugi Holdings Co Ltd | 37.44bn | 1.11bn | 22.32bn | 7.73k | 19.23 | 1.81 | 12.29 | 0.5962 | 121.46 | 121.46 | 4,114.16 | 1,289.59 | 2.01 | 6.52 | 18.18 | -- | 5.92 | 6.11 | 8.99 | 9.30 | 30.74 | 30.38 | 2.95 | 3.21 | 0.8443 | -- | 0.0036 | 23.94 | 11.51 | 8.79 | 15.64 | 4.14 | 12.58 | 2.71 |
| Welcia Holdings Co Ltd | 61.22bn | 1.33bn | 24.36bn | 14.87k | 18.07 | 2.01 | 9.52 | 0.3978 | 127.85 | 127.85 | 5,879.06 | 1,150.65 | 2.24 | 6.37 | 20.73 | -- | 4.84 | 5.76 | 8.27 | 10.23 | 30.40 | 30.81 | 2.16 | 2.51 | 0.5507 | 44.99 | 0.2529 | 23.81 | 6.38 | 9.33 | -2.14 | 8.71 | 2.59 | 10.12 |
| Tsuruha Holdings Inc | 50.93bn | 1.36bn | 24.42bn | 11.30k | 17.68 | 1.68 | 10.24 | 0.4796 | 554.77 | 554.77 | 20,729.87 | 5,827.22 | 1.89 | 4.89 | 22.41 | 89,640,290.00 | 5.56 | 6.03 | 8.75 | 10.01 | 30.42 | 29.35 | 2.94 | 3.16 | 0.6803 | 38.96 | 0.1437 | 35.08 | 5.94 | 7.58 | 18.09 | 0.3683 | 21.98 | 12.23 |
| Dashenlin Pharmaceutical Group Co Ltd | 26.12bn | 1.39bn | 25.53bn | 39.50k | 18.33 | 3.45 | -- | 0.9774 | 1.13 | 1.13 | 21.21 | 6.01 | 1.22 | 3.98 | 24.79 | 611,500.30 | 6.94 | 7.20 | 12.91 | 13.66 | 36.30 | 38.65 | 5.70 | 5.77 | 0.6101 | 10.57 | 0.535 | 49.96 | 26.78 | 23.42 | 30.90 | 16.87 | 9.13 | 17.57 |
| Sundrug Co Ltd | 37.06bn | 1.41bn | 27.14bn | 6.37k | 18.81 | 2.14 | 12.70 | 0.7323 | 240.46 | 240.46 | 6,301.25 | 2,109.59 | 2.02 | 6.33 | 28.21 | 115,661,800.00 | 7.70 | 8.25 | 11.25 | 12.02 | 25.35 | 24.81 | 3.82 | 3.85 | 0.9663 | -- | 0.00 | 35.78 | 6.43 | 4.12 | 7.76 | 0.6943 | 15.95 | 10.76 |
| Cosmos Pharmaceutical Corp | 47.11bn | 1.25bn | 29.18bn | 5.29k | 23.10 | 2.56 | 13.17 | 0.6194 | 627.89 | 627.89 | 23,646.83 | 5,659.54 | 2.32 | 9.86 | 2,065.50 | 177,071,100.00 | 6.16 | 7.02 | 10.96 | 13.37 | 19.65 | 20.03 | 2.66 | 3.18 | 0.1784 | 1,267.96 | 0.0456 | 12.24 | 9.57 | 8.21 | 2.77 | 6.18 | 9.63 | 17.32 |
| Yifeng Pharmacy Chain Co Ltd | 24.25bn | 1.56bn | 47.92bn | 35.92k | 30.80 | 4.70 | -- | 1.98 | 1.42 | 1.42 | 22.17 | 9.33 | 1.09 | 4.14 | 15.49 | 624,441.20 | 8.00 | 6.91 | 14.82 | 11.90 | 38.35 | 39.04 | 7.31 | 6.57 | 0.726 | 44.59 | 0.4505 | 23.25 | 29.75 | 32.84 | 42.54 | 32.19 | 23.23 | 19.40 |
| MatsukiyoCocokara & Co | 50.66bn | 2.54bn | 48.04bn | 13.66k | 18.42 | 1.84 | 13.28 | 0.9482 | 120.90 | 120.90 | 2,406.55 | 1,210.69 | 1.44 | 4.64 | 16.07 | 73,757,340.00 | 7.28 | 6.75 | 9.37 | 8.90 | 34.55 | 32.70 | 5.05 | 4.36 | 1.34 | -- | 0.0369 | 28.16 | 30.31 | 11.22 | 17.94 | 12.25 | 27.89 | 4.94 |
| JD Health International Inc | 57.86bn | 2.31bn | 79.09bn | 3.12k | 33.89 | 1.48 | 30.87 | 1.37 | 0.7318 | 0.7318 | 18.29 | 16.73 | 0.8526 | 7.52 | 107.39 | 18,555,510.00 | 3.41 | -8.61 | 4.53 | -10.70 | 22.17 | 22.76 | 4.00 | -10.39 | 2.93 | -- | 0.0043 | -- | 14.54 | 45.64 | 463.49 | 58.38 | -- | -- |
Data as of Apr 26 2024. Currency figures normalised to JD Health International Inc's reporting currency: Hong Kong Dollar HKD
6.52%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Krane Funds Advisors LLCas of 04 Apr 2024 | 43.90m | 1.38% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 40.52m | 1.27% |
| JPMorgan Asset Management (Asia Pacific) Ltd.as of 31 Mar 2024 | 18.95m | 0.59% |
| Hang Seng Investment Management Ltd.as of 03 Apr 2024 | 18.86m | 0.59% |
| BlackRock Fund Advisorsas of 04 Apr 2024 | 18.65m | 0.59% |
| CSOP Asset Management Ltd.as of 03 Apr 2024 | 18.25m | 0.57% |
| Artisan Partners LPas of 31 Dec 2023 | 13.15m | 0.41% |
| China Asset Management Co., Ltd.as of 30 Jun 2023 | 13.02m | 0.41% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 11.88m | 0.37% |
| T. Rowe Price International Ltd.as of 31 Mar 2024 | 10.89m | 0.34% |
More ▼
Data from 31 Dec 2023 - 04 Apr 2024Source: FactSet Research Systems Inc.
